The American Journal of Managed Care

FDA Safety Warnings and Trends in Testosterone Marketing to Physicians

This article presents an evaluation of testosterone marketing practices around the period of the testosterone label warning by physician specialty and rural vs urban primary care service area. In ...
manilatimes

Marius Pharmaceuticals Helps Drive FDA's Landmark Testosterone Label Update, Removing Black Box Warning

RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, is pleased to announce that the U.S. Food and Drug Administration (FDA) has implemented significant labeling changes for ...
CBS News

Telehealth websites promise cure for "male menopause" despite FDA ban on off-label ads

Online stores sprang up during the COVID-19 pandemic's telehealth boom touting testosterone as a cure-all for men's age-related illnesses — despite FDA rules issued years ago restricting such "low ...
Healio

Removal of boxed warning clears testosterone of heart-related risk, but concerns remain

Please provide your email address to receive an email when new articles are posted on . The FDA removed a warning about CV risk from testosterone product labels after a randomized trial showed no link ...
Healio

FDA recommends removing black box warning for CV risk from all testosterone product labels

Please provide your email address to receive an email when new articles are posted on . The FDA stated a warning about adverse CV outcomes with testosterone therapy can be removed based on data from ...